Management Principles for Acute Illness in Patients With Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 30 12 2020
medline: 11 5 2021
entrez: 29 12 2020
Statut: ppublish

Résumé

Medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) is a fatty acid oxidation disorder in which the patient is unable to break down fats to produce energy. This disorder places children at risk for metabolic decompensation during periods of stress, such as routine childhood illnesses. The intent of this clinical report is to provide pediatricians with additional information regarding the acute clinical care of patients with MCADD. Although each patient with MCADD will still be expected to have a primary metabolic physician, the involvement of the primary care provider is crucial as well. Appropriate treatment of children with MCADD can lead to avoidance of morbidity and mortality.

Identifiants

pubmed: 33372121
pii: peds.2020-040303
doi: 10.1542/peds.2020-040303
pii:
doi:

Substances chimiques

Sweetening Agents 0
Acyl-CoA Dehydrogenase EC 1.3.8.7
Glucose IY9XDZ35W2
Carnitine S7UI8SM58A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHGRI NIH HHS
ID : U01 HG007674
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS134349
Pays : United States

Investigateurs

Emily Chen (E)
Tracy L Trotter (TL)
Leah W Burke (LW)
Timothy A Geleske (TA)
Robert J Hopkin (RJ)
Wendy J Introne (WJ)
Michael J Lyons (MJ)
Angela E Scheuerle (AE)
Joan M Stoler (JM)
Debra L Freedenberg (DL)
Marilyn C Jones (MC)

Informations de copyright

Copyright © 2021 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Auteurs

Tracy L McGregor (TL)

Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Susan A Berry (SA)

Division of Genetics and Metabolism, University of Minnesota, Twin Cities, Minneapolis, Minnesota.

Katrina M Dipple (KM)

Division of Genetic Medicine, University of Washington, Seattle, Washington; and.

Rizwan Hamid (R)

Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee rizwan.hamid@vumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH